Pharmacists’ Role in CAR T-Cell and Gene Therapy Highlighted at 2026 ASTCT Tandem Meeting in Salt Lake City

Pharmacists’ involvement in CAR T-cell therapy and gene therapy took center stage at the 2026 ASTCT Tandem Meeting held in Salt Lake City. Experts convened to discuss the evolving role of pharmacists in these advanced treatment modalities, highlighting their contributions to patient care and the management of complex therapies.

The meeting addressed key topics surrounding CAR T-cell therapy and gene therapy, including pharmacists’ responsibilities in medication preparation, administration protocols, and monitoring for adverse effects. Discussions also focused on strategies for optimizing patient outcomes through interdisciplinary collaboration and education. The event provided a platform for healthcare professionals to exchange insights on navigating challenges associated with these innovative treatments as they continue to expand within clinical practice.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

Author

GOAI